Acacia Pharma, Inc. is a commercially driven hospital pharmaceutical group focused on the development and commercialization of new nausea and vomiting treatments for surgical and cancer patients. The Company has identified important and commercially attractive unmet needs in nausea and vomiting and has discovered two product candidates based on the same active ingredient, amisulpride, to meet those needs. Join our team: http://www.acaciapharma.com/join-our-team/current-openings
Looking for a particular Acacia Pharma employee's phone or email?
The Acacia Pharma annual revenue was $8 million in 2026.
Edward Borkowski is the Director and Chairman, Audit Committee and Compensation Committee and Governance Committee of Acacia Pharma.
10 people are employed at Acacia Pharma.
Acacia Pharma is based in Indianapolis, Indiana.
The NAICS codes for Acacia Pharma are [32, 3254, 32541, 325].
The SIC codes for Acacia Pharma are [283, 28].